Our research provides significant insights into the roles of NUTM2A‐AS1 in neuroblastoma (NB), highlighting its contributions to cisplatin resistance, oncogenic activities and modulation of immune evasion mechanisms in NB cells. Here, NUTM2A is linked to neuroblastoma.